Environmental risk of pharmaceuticals: Let us look at the whole package

Br J Clin Pharmacol. 2022 Aug;88(8):3918-3919. doi: 10.1111/bcp.15311. Epub 2022 Mar 23.

Unax Lertxundi¹, Saioa Domingo-Echaburu², Gorka Orive^{3

4

5

6

7}

¹ Bioaraba Health Research Institute, Osakidetza Basque Health Service, Araba Mental Health Network, Araba Psychiatric Hospital, Pharmacy Service, Vitoria-Gasteiz, Spain.
² Osakidetza Basque Health Service, Debagoiena Integrated Health Organisation, Pharmacy Service, Arrasate, Spain.
³ NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain.
⁴ Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz, Spain.
⁵ University Institute for Regenerative Medicine and Oral Implantology - UIRMI (UPV/EHU-Fundación Eduardo Anitua), Vitoria, Spain.
⁶ Singapore Eye Research Institute, Singapore.
⁷ Bioaraba, NanoBioCel Research Group, Vitoria-Gasteiz, Spain.

No abstract available

Keywords: drug pollution; environmental risk assessment; pharmaceuticals in the environment.

Publication types